ProMIS Neurosciences Inc (PMN): Next-Year EPS Estimate 33.33%
As of 2026-05-18, ProMIS Neurosciences Inc (PMN) has a next-year EPS growth estimate of 33.33%.
On 2026-05-17, analyst consensus for PMN's next-year EPS growth shifted from 65.13% to 33.33% — a negative change of 31.80 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 76.38%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 33.33%
- EPS growth this year
- 76.38%
- EPS next quarter (est)
- -$1.41
- Last price
- $10.55
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-18 | 33.33% | 76.38% | -$1.41 | $10.55 |
| 2026-05-17 | 33.33% | 76.38% | -$1.41 | $10.39 |
| 2026-03-25 | 65.13% | N/A | N/A | $15.85 |
| 2026-03-25 | 30.07% | N/A | N/A | $15.85 |
| 2026-03-25 | 30.07% | N/A | N/A | $15.85 |
| 2026-03-24 | 65.13% | N/A | N/A | $17.43 |
| 2026-03-24 | 65.13% | N/A | N/A | $17.43 |
| 2026-03-24 | 65.13% | N/A | N/A | $17.43 |
| 2026-03-23 | 65.13% | N/A | N/A | $17.77 |
| 2026-03-20 | 65.13% | N/A | N/A | $17.60 |
| 2026-03-19 | 65.13% | N/A | N/A | $18.21 |
| 2026-03-18 | 65.13% | N/A | N/A | $17.00 |
| 2026-03-17 | 65.13% | N/A | N/A | $19.55 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is ProMIS Neurosciences Inc's next-year EPS growth estimate?▾
As of 2026-05-18, ProMIS Neurosciences Inc (PMN) has a next-year EPS growth estimate of 33.33%, based on analyst consensus.
When was the latest EPS estimate revision for PMN?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 65.13% to 33.33%.
What sector and industry does ProMIS Neurosciences Inc belong to?▾
ProMIS Neurosciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PMN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. ProMIS Neurosciences Inc (PMN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports